At Coho Biologics we specialize in RNA and protein biological testing, providing rapid testing solutions for the biotechnology and pharmaceutical industry.
Darrick Carter, Ph.D.
Dr. Darrick Carter, Scientific Advisor, is a biochemist/biophysicist with over 20 years of biotechnology experience most recently serving as CSO of HDT Bio and VP of Adjuvant Technologies at AAHI (Formerly IDRI). He has founded five companies beginning with an internet startup. At Corixa he led a new tuberculosis vaccine into human trials. He started PAI as a bioinformatics company using proprietary artificial neural nets. He helped spin out Dharma Therapeutics a specialty pharma company for drug delivery. Next, he co-founded a company improving cancer outcomes, Compliment Corp. He is an inventor on over 120 patents and applications with more than 100 publications.
Sean Gray, Ph.D.
Dr. Gray is a biotech veteran with over 20 years experience in for-profit, non-profit, and government institutions. He has been awarded multiple NIH grants for the development of vaccines for intestinal and urinary schistosomiasis, and HIV. He oversaw the manufacture and release testing of Sm-p80 for SchistoShield™, the first ever human vaccine for schistosomiasis. This vaccine is currently in Phase 1b clinical trials in Africa. He is inventor/co-inventor on 5 patents or applications including a novel antigen for inclusion in a canine heartworm vaccine. He has co-authored more than 30 peer-reviewed publications and two book chapters.
Jenn Davis, M.T., C.L.S.
Institutional Biosafety Committee (IBC)
On behalf of the institution, IBCs review research involving recombinant or synthetic nucleic acid molecules for compliance with the NIH Guidelines.